The EMSY gene encodes a protein that interacts with Brca2 and is amplifi ed in some sporadic cases of human breast cancer. To examine whether overex-pression of EMSY would mimic the chromosome instability phenotype that is associated with the loss of Brca2 function, we constructed a lentiviral vector (Lenti-EMSY/GFP) that en-codes a truncated form of the Emsy protein, including its Brca2-interacting domain, and green fl uorescent protein (GFP) and used it to transduce hu-man telomerase- immortalized human breast epithelial (184-hTert) cells
DNA hypermethylation is extensively explored as therapeutic target for gene expression modulation in...
Epithelial to mesenchymal transition (EMT) is a developmental program that has been implicated in pr...
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel UniversityBRC...
EMSY is a novel gene encoding a protein that binds to the tumor suppressor BRCA2. EMSY maps to 11q1...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
AbstractThe BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicat...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
AbstractIn this issue, Hughes-Davies et al. describe a novel gene product, EMSY, which suppresses th...
AbstractCheckpoint proteins are activated in response to genotoxic insults or replication stress to ...
Abstract: Mutations in the breast cancer susceptibility gene 2 (BRCA2) are commonly found in familia...
Recent work from others and us revealed interactions between the Sin3/HDAC complex, the H3K4me3 deme...
We generated a cDNA expression library from a human mammary epithelial cell line for detection of no...
Nonviral gene delivery systems are rapidly becoming a desirable and applicable method to overexpress...
We have used cultured human mammary epithelial cells (HMEC) and breast tumor-derived lines to gain i...
DNA hypermethylation is extensively explored as therapeutic target for gene expression modulation in...
Epithelial to mesenchymal transition (EMT) is a developmental program that has been implicated in pr...
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel UniversityBRC...
EMSY is a novel gene encoding a protein that binds to the tumor suppressor BRCA2. EMSY maps to 11q1...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
AbstractThe BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicat...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
The BRCA2 gene is mutated in familial breast and ovarian cancer, and its product is implicated in DN...
AbstractIn this issue, Hughes-Davies et al. describe a novel gene product, EMSY, which suppresses th...
AbstractCheckpoint proteins are activated in response to genotoxic insults or replication stress to ...
Abstract: Mutations in the breast cancer susceptibility gene 2 (BRCA2) are commonly found in familia...
Recent work from others and us revealed interactions between the Sin3/HDAC complex, the H3K4me3 deme...
We generated a cDNA expression library from a human mammary epithelial cell line for detection of no...
Nonviral gene delivery systems are rapidly becoming a desirable and applicable method to overexpress...
We have used cultured human mammary epithelial cells (HMEC) and breast tumor-derived lines to gain i...
DNA hypermethylation is extensively explored as therapeutic target for gene expression modulation in...
Epithelial to mesenchymal transition (EMT) is a developmental program that has been implicated in pr...
This thesis was submitted for the degree of Doctor of Philosophy and awarded by Brunel UniversityBRC...